This article is more than 5 years old. Information may no longer be current.

Top stories in endocrinology: Diabetes management transformed by new tech, HbA1c alternatives

A presentation at the Cardiometabolic Heath Congress that discussed trends in diabetes care — particularly new continuous glucose monitoring devices and HbA1c alternatives — was the week’s top story in endocrinology.

Another top story was a study that found adults who consumed more fruit juice and artificially sweetened beverages were more likely to develop type 2 diabetes than those who consumed less.

‘Digiceuticals,’ new CGM devices, HbA1c alternatives transform diabetes management

The growing abundance of technology options for better diabetes management and the trend away from HbA1c as the only evaluation metric for the condition are important parallel phenomena, according to a speaker at the Cardiometabolic Health Congress. Read more.

Type 2 diabetes risk rises with more fruit juice, artificially sweetened beverage consumption

Adults who consume larger quantities of sweetened beverages, including fruit juices and those made with artificial sweeteners, are more likely to develop type 2 diabetes than those who drink smaller quantities, according to findings published in Diabetes Care. Read more.

Multifactorial diabetes intervention reduces long-term HbA1c, BP more effectively than standard care

Adults with type 2 diabetes who took part in a multifactorial intervention that included structured education had their long-term measures of HbA1c, blood pressure and coronary heart disease risk lowered more substantially than those who received usual care, according to findings published in Diabetic Medicine. Read more.

Icosapent ethyl appropriate to use to reduce CV risk, despite pending questions

Findings of cardiovascular benefit with icosapent ethyl treatment from the REDUCE-IT trial have already revealed actionable clinical implications, but determining whether triglyceride reductions or eicosapentaenoic acid increases are the key mechanisms will be the focus of continuing research, according to a speaker at the Cardiometabolic Heath Congress. Read more.

Severe obesity increases likelihood of PCOS, metabolic syndrome

Approximately 1 in 4 Swedish women with severe obesity has polycystic ovary syndrome and more than 40% have metabolic syndrome, although women with and without PCOS had comparable body composition measurements and experienced similar weight loss during a dietary intervention, according to findings published in Clinical Endocrinology. Read more.